Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Post by valuator50on Dec 27, 2018 6:18pm
258 Views
Post# 29161947

This deal should make Aphria shorts very happy

This deal should make Aphria shorts very happyFirst, this is a reverse takeover proposal where Aphria shareholders would end up with about two-thirds of the equity in the merged company.

GGB is the product of a reverse takeover done only last month with the aparent motive to keep the company alive - it was essentially insolvent at the time, with little revenue, working cap deficiency of over $50MM and no earnings to service substantial interest requirements. At that time (Nov 9th), shares of the newly merged GGB were deemed to have a value of $.36 - that's right, 36 cents and not $7.

The core strength of GGB seems to be its ability to issue lots of news releases in order to pump the share price up to about $5 but it has never been near $7 and it is a dream to think it could raise $300MM at $7. 

Using the average share price of GGB over the last month of about $3.25, the valuation for the Aphria shares would be about $5.10, more than 30% below where they closed today.

Hard to see how this proposed takeover goes anywhere.
Bullboard Posts